Targeted foreign gene expression in spinal cord neurons using poliovirus replicons

References

• Abe S., Ota Y., Koike S., Kurata T., Horie H., Nomura T., Hashizume S., Nomoto A. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology 1995; 206: 1075–1083
   Google Scholar
• Ansardi D. C., Porter D. C., Morrow C. D. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides P1 capsid precursor in trans. J Virol 1993; 67: 3684–3690
   Google Scholar
• Bartholdi D., Schwab M. E. Expression of proinflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 1997; 9: 1422–1438
   PubMed Web of Science ®Google Scholar
• Blesch A., Tuszynski M. H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol 1997; 148: 444–452
   PubMed Web of Science ®Google Scholar
• Blondel B., Duncan G., Couderc T., Delepeyroux F., Panis N., Coldre-Gampan F. Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells. J Neurovirol 1998; 4: 1–26
   PubMed Web of Science ®Google Scholar
• Bodian D. Histopathologic basis of clinical findings in poliomyelitis. Am J Med 1949; 6: 563–578
   PubMed Web of Science ®Google Scholar
• Choi W. S., Pal-Ghosh R., Morrow C. D. Expression of human immunodeficiency virus type 1 (HIV-1), gag, pol and env proteins from chimeric HIV-1 poliovirus minireplicons. J Virol 1991; 65: 2875–2883
   PubMed Web of Science ®Google Scholar
• Chambers R., Gillespie G. Y., Soroceanu L., Andreansky S., Chatterjee S., Chou J., Roizman B., Whitley R. J. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci USA 1995; 92: 1411–1415
   PubMed Web of Science ®Google Scholar
• Deatly A. M., Taffs R. E., McAuliffe J. M., Nawoschik S. P., Coleman J. W., McMullen G., Weeks-Levy C., Johnson A. J., Racaniello V. R. Characterization of mouse lines transgenic with the human poliovirus receptor gene. Microbiol Pathogen 1998; 25: 43–54
   Google Scholar
• Freistadt M. Distribution of the poliovirus receptor in human tissue. Cellular receptors for animal viruses, E. Wimmer. Cold Springs Harbor Laboratory Press, New York 1994; 445–461
   Google Scholar
• Freistadt M. S., Kaplan G., Racaniello V. R. Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol 1990; 10: 5700–5706
   PubMedGoogle Scholar
• Girard S., Couderc T., Destombes J., Thiesson D., Delpeyroux F., Blondel B. Poliovirus induces apoptosis in the mouse central nervous system. J Virol 1999; 73: 6066–6072
   PubMedGoogle Scholar
• Hashimoto I., Hagiwara A., Komatsu T. Ultra-structural studies on the pathogenesis of poliomyelitis in monkey infected with poliovirus. Acta Neuropathol 1984; 64: 53–60
   Google Scholar
• Holland J. J. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 1961; 15: 312–326
   PubMedGoogle Scholar
• Jablonski S. A., Muo M., Morrow C. D. Enzymatic activity of poliovirus RNA polymerase mutants with single amino acid changes in the conserved YGDD amino acid motif. J Virol 1991; 65: 4564–4572
   Google Scholar
• Joachims M., Breugel P. C., Lloyd R. E. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 1999; 73: 718–727
   PubMedGoogle Scholar
• Kim D. H., Gutin P. H., Noble L. J., Nathan D., Yu J. S., Nockels R. P. Treatment of genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat. NeuroReport 1996; 7: 2221–2225
   PubMed Web of Science ®Google Scholar
• Koch F., Koch G. The molecular biology of poliovirus. Springer-Verlag, Vienna 1985; 203–253
   Google Scholar
• Koike S., Taya C., Kurata T., Abe I., Ise I., Yonekawa H., Nomoto A. Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci USA 1991; 85: 951–955
   Google Scholar
• Mendelsohn C. L., Wimmer E., Racaniello V. R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989; 56: 855–865
   PubMed Web of Science ®Google Scholar
• Porter D. C., Ansardi D. C., Choi W. S., Morrow C. D. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 gag and pol proteins upon infection. J Virol 1993; 67: 3712–3719
   Google Scholar
• Porter D. C., Ansardi D. C., Morrow C. D. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene using a complementation system which provides the P1 capsid protein in trans. J Virol 1995; 69: 1548–1555
   PubMed Web of Science ®Google Scholar
• Porter D. C., Ansardi D. C., Wang J., McPherson S., Moldoveanu Z., Morrow C. D. Demonstration of the specificity of poliovirus encapsidation using novel replicon which encodes enzymatically active firefly luciferase. Virology 1998; 243: 1–11
   Google Scholar
• Ren R., Costantini F., Gorgacz E. J., Lee J. J., Racaniello V. R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 1990; 63: 353–362
   PubMed Web of Science ®Google Scholar
• Ren R., Racaniello V. R. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 1992; 66: 296–304
   PubMed Web of Science ®Google Scholar
• Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.-F., Achong M. K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311–320
   PubMed Web of Science ®Google Scholar